Protara Therapeutics, Inc.TARANASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank46
Studio
Year-over-Year Change

Free cash flow yield

Latest
-24.73%
↑ 56% vs avg
Percentile
P46
Within normal range
Streak
2 yr
Consecutive growthElevated
Average
-56.04%
Historical baseline
PeriodValueYoY Change
2025-24.73%+25.0%
2024-32.99%+81.3%
2023-176.52%-100.4%
2022-88.07%-90.3%
2021-46.29%-233.8%
2020-13.87%+41.0%
2019-23.51%-134.0%
2018-10.04%+85.3%
2017-68.21%+10.4%
2016-76.14%-